While this week is yet not over it could be worth observing how $SPPI closes out this week as she seems to be making all the right moves to take out this weekly resistance level and continue higher. I'm noticing she has been playing by solid technical moves lately, retesting breakout candle bottoms and tops, going bearish and bullish with good signals, and she...
Short fall after today's news of CEO and top leadership replacement. Company still maintains strong buy from analysts. Current dip to news traders. Oscillators, down; should pick up after jolt.
SPPI is graciously providing us with another beautiful entry place pullback from overbought, support caught on 10 day EMA and then a bullish engulfing candle.
Entry: 14.15
Stop Loss: 13.25
Profit Target: 16.00
PLAN - WAIT for the pullback and bounce.
If he bounce order a limit order @ 6.85 for a 10% profit at friday WK 17.
Dont trade NOW!!! WAIT!!!
Maybe on Monday!!
Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company operates through developing and commercializing oncology and hematology drug products segment. It focuses on developing ROLONTIS and POZIOTINIB. ROLONTIS is being investigated for the treatment of chemotherapy-induced neutropenia. POZIOTINIB is an oral pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR, HER) Family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations.
This website uses cookies to ensure you get the best experience on our website. To learn more about cookies, including how to control cookies, please read our Cookies Policy.
SPPI
